본문 바로가기(Skip Contents)
ENGLISH
KOREAN
HOME
ABOUT US
Overview
History
Manufacturing facility
Our Company
PRODUCT
ALS (NeuroNata-R®)
Lou Gehrig's disease
PIPELINE
Pipeline
SLE
CA
R&D
Stem Cell Therapy
IR
Stock Information
Disclosures
Finances
Announcement of Settlement
IR Inquiry
PR
Press Report
Notice
Media
Online Inquiry
전체메뉴
전체메뉴
ABOUT US
Overview
History
Manufacturing facility
Our Company
PRODUCT
ALS (NeuroNata-R®)
Lou Gehrig's disease
PIPELINE
Pipeline
SLE
CA
R&D
Stem Cell Therapy
IR
Stock Information
Disclosures
Finances
Announcement of Settlement
IR Inquiry
PR
Press Report
Notice
Media
Online Inquiry
HOME
ENGLISH
KOREAN
ABOUT US
Overview
History
Manufacturing facility
Our Company
PRODUCT
ALS (NeuroNata-R®)
Lou Gehrig's disease
PIPELINE
Pipeline
Target Disease
Lupus
R&D
Stem Cell Therapy
IR
Stock Information
Disclosures
Finances
Announcement of Settlement
IR Inquiry
PR
Press Report
Notice
Media
Online Inquiry
PR
Corestem is a biopharmaceutical company that
researches and commercializes stem cell technology.
Press Report
Notice
Media
Online Inquiry
Press Report
Notice
Media
Online Inquiry
공지사항
15
2023.03
제20 정기주주총회 소집공고
READ MORE
01
2022.12
흡수합병의 보고 총회를 갈음하는 공고
READ MORE
11
2022.10
합병에 따른 채권자 이의제출 공고의 건
READ MORE
19
2022.09
주식매수청구권 행사 안내 (첨부파일 포함)
READ MORE
19
2022.09
주주총회소집공고
READ MORE
1
2
3
4